Cinnamon, Brain Health, and Memory: The Emerging Evidence

The Most Important Caveat First

Cinnamon and Alzheimer's Disease: The Tau Protein Connection

Two hallmarks of Alzheimer's disease are the accumulation of amyloid-β plaques and the formation of neurofibrillary tangles made of tau protein. Peterson et al. (2009, Journal of Alzheimer's Disease) identified that cinnamon extract — specifically the compounds cinnamaldehyde and epicatechin — inhibit tau aggregation and amyloid-β fibril formation in vitro.

The mechanism involves the compounds binding to tau protein, preventing the conformational changes that lead to tangle formation. This is biologically meaningful because tau tangles physically disrupt neuronal communication.

Animal models have extended this finding. In mouse models of Alzheimer's, CEppt (a cinnamon bark extract) reduced amyloid plaque load and improved cognitive performance. These results are promising but have not yet been replicated in controlled human clinical trials.

Sodium Benzoate: Cinnamon's Neuroprotective Metabolite

When cinnamon is metabolised in the body, one of its metabolites is sodium benzoate (NaB). Jana et al. (2013, Journal of Neuroimmune Pharmacology) demonstrated in animal models that NaB:

• •Upregulates BDNF (Brain-Derived Neurotrophic Factor) — the key protein that supports neuron survival and growth
• •Increases NT-3 (Neurotrophin-3) in the hippocampus — the brain region responsible for memory formation
• •Improved learning, memory, and neurological function in mouse models
• •Reduced neuroinflammation markers associated with neurodegenerative progression

BDNF is sometimes called "Miracle-Gro for the brain" — it's one of the most important molecules for neuroplasticity and memory consolidation. The fact that a common cinnamon metabolite upregulates BDNF is genuinely interesting and warrants further human investigation.

The Human Cognitive Study

Wahlqvist et al. (2016, Nutritional Neuroscience) conducted one of the few human studies on cinnamon and cognition. In older adults with prediabetes, cinnamon supplementation compared to controls led to:

This is significant because it's a human study showing real cognitive improvements. The connection to blood sugar control is also important — diabetes itself is associated with 50–65% increased risk of Alzheimer's disease. Anything that meaningfully improves insulin sensitivity may also reduce neurodegeneration risk over time.

Parkinson's Disease Research

Khasnavis & Bhatt (2014, Journal of Neuroimmune Pharmacology) demonstrated that ground cinnamon metabolised to sodium benzoate in animal models led to:

• •Protection of dopaminergic neurons (the neurons lost in Parkinson's disease)
• •Normalisation of neurotrophic factors (BDNF and GDNF) in the substantia nigra
• •Reduced α-synuclein accumulation (the toxic protein clumps in Parkinson's)
• •Improved motor function in Parkinson's mouse models

This research is entirely pre-clinical. No human trials in Parkinson's patients have been conducted. The findings are hypothesis-generating, not conclusive.

The Diabetes–Brain Connection: An Important Bridge

Perhaps the most practically significant brain health argument for cinnamon isn't its direct neuroprotective effects — it's the indirect effect via blood sugar control. Research consistently links:

If cinnamon's well-established blood sugar effects reduce the risk of developing or worsening insulin resistance, there's a plausible protective downstream effect on brain health — even if that brain benefit isn't directly tested in trials.

Related Articles